Auckland, New Zealand

Amir Ashoorzadeh

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Manukau, NZ (2019)
  • Auckland, NZ (2015 - 2023)

Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Amir Ashoorzadeh: Pioneering Innovations in Cancer Treatment**

Introduction

Amir Ashoorzadeh, an esteemed inventor based in Auckland, New Zealand, has made significant contributions to the field of medicine with a total of eight patents to his name. His work predominantly focuses on developing prodrug compounds and kinase inhibitors aimed at treating hyperproliferative disorders, including various forms of cancer.

Latest Patents

Among his latest patents, Amir has introduced groundbreaking prodrug compounds activated by the AKR1C3 enzyme. These compounds are designed to target neoplasm tissue selectively, allowing for the transformation into an active cytotoxic form upon contact with the AKR1C3 enzyme. This targeted approach enables effective ablation of AKR1C3-expressing cancer cells, thereby holding great promise in cancer treatment and the management of other hyperproliferative diseases.

Another notable patent covers FGFR kinase inhibitors and prodrugs associated with a diverse range of applications. These compounds are aimed at treating conditions such as retinopathy, psoriasis, rheumatoid arthritis, and several other severe diseases, thereby showcasing Amir's commitment to addressing significant medical challenges through innovative solutions.

Career Highlights

Throughout his career, Amir Ashoorzadeh has been associated with reputable organizations, including Auckland Uniservices Limited and Health Innovation Ventures B.V. His roles in these institutions have allowed him to push the boundaries of medical science and develop novel therapeutic interventions.

Collaborations

Amir has collaborated with notable professionals such as Jeffrey Bruce Smaill and Adam Vorn Patterson. Through these partnerships, he has engaged in meaningful research and development, further advancing the innovation landscape within the medical field.

Conclusion

In summary, Amir Ashoorzadeh stands out as a prominent inventor whose work holds promise for improving treatment options for hyperproliferative disorders. His innovative patents reflect a deep commitment to medical advancements and underscore his significant role in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…